Psyence Biomedical Ltd (NASDAQ:PBM) currently has a daily average trading volume of 2.69M but it saw 4048457 shares traded in last market. With a market cap of 5.24M USD, the company’s current market price of $1.34 came rising about 10.74 while comparing to the previous closing price of $1.21. In past 52 weeks, the stock remained buoying in the range of price level as high as $323.25 and as low as $1.13.
Taking a look at 20-day trading activity of Psyence Biomedical Ltd (PBM) gives us an average price of $1.3793, while its current price level is -99.59% below from 52-week high level whereas it is 18.58% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.7277 while that of 200 days or SMA-200 reads an average of $19.7038. A closer look into the stock’s movement over the week reveals that its volatility is standing at 9.36% during that period while stretching the period over a month that increases to 13.82%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.66 which implies that the stock is in neutral territory.
Over the week, PBM’s stock price is moving -2.19% down while it is -20.24% when we observe its performance for the past one month. Year-to-date it is -36.49% down and over the past year, the stock is showing a downside performance of -96.72%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Psyence Biomedical Ltd’s total number of outstanding shares is 0.72M with 2.41% of that held by the insiders while 21.86% of its common stock has been owned by the institutions. Stock’s beta reads -0.44.
